In conclusion, our findings suggest that therapeutic approaches to enhance ADAMTS13 levels could potentially be a promising strategy to ameliorate diabetes-induced retinal inflammation and vascular dysfunction. The gene discussed is ADAMTS13; the disease is diabetes mellitus.